HRP20160774T1 - Pripravci za liječenje umora povezanog s karcinomom - Google Patents

Pripravci za liječenje umora povezanog s karcinomom Download PDF

Info

Publication number
HRP20160774T1
HRP20160774T1 HRP20160774TT HRP20160774T HRP20160774T1 HR P20160774 T1 HRP20160774 T1 HR P20160774T1 HR P20160774T T HRP20160774T T HR P20160774TT HR P20160774 T HRP20160774 T HR P20160774T HR P20160774 T1 HRP20160774 T1 HR P20160774T1
Authority
HR
Croatia
Prior art keywords
extract
ginsenoside
cancer
zingiber officinale
treatment
Prior art date
Application number
HRP20160774TT
Other languages
English (en)
Inventor
Ezio Bombardelli
Fabrizio CORTI
Original Assignee
Indena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S.P.A. filed Critical Indena S.P.A.
Publication of HRP20160774T1 publication Critical patent/HRP20160774T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2813Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Claims (5)

1. Pripravci koji sadrže sljedeće: (a) ekstrakt Panax ginseng CA Mayer, (b) ekstrakt Zingiber officinale, (c) ekstrakt Echinacea angustifolia te (d) fosfolipidni kompleks silbina s fosfolipidima kao aktivnim tvarima, u smjesi s pogodnim ekscipijenioma.
2. Pripravci prema patentnom zahtjevu 1, naznačeni time da su ekstrakti Zingiber officinale i Echinacea angustifolia lipofilni ekstrakti.
3. Pripravci prema patentnom zahtjevu 1 ili 2, naznačeni time da je u ekstraktu ginsenga sadržaj ginsenozida 8%, a omjer ginsenozida Rgl/ginsenozida Rb1 jest 0.5/1, da je u ekstraktu Zingiber officinale sadržaj gingerola 30% te da je u ekstraktu Echinacea angustifolia sadržaj izobutilamida veći od 20% po masi.
4. Pripravci prema jednom ili više patentnih zahtjeva 1 do 3 u obliku tableta, pilula sa šećernom ovojnicom, mekih i tvrdih želatinskih kapsula ili celuloznih kapsula.
5. Pripravci prema patentnim zahtjevima 1-4 za upotrebu u liječenju umora povezanog s karcinomom.
HRP20160774TT 2012-07-27 2016-07-01 Pripravci za liječenje umora povezanog s karcinomom HRP20160774T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT001317A ITMI20121317A1 (it) 2012-07-27 2012-07-27 Composizioni per il trattamento della fatica oncologica
EP13744458.4A EP2877192B1 (en) 2012-07-27 2013-07-11 Compositions for treatment of cancer-related fatigue
PCT/EP2013/064711 WO2014016137A1 (en) 2012-07-27 2013-07-11 Compositions for treatment of cancer-related fatigue

Publications (1)

Publication Number Publication Date
HRP20160774T1 true HRP20160774T1 (hr) 2016-08-12

Family

ID=46939795

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20160774TT HRP20160774T1 (hr) 2012-07-27 2016-07-01 Pripravci za liječenje umora povezanog s karcinomom

Country Status (22)

Country Link
US (1) US9566309B2 (hr)
EP (1) EP2877192B1 (hr)
JP (1) JP6129314B2 (hr)
KR (1) KR102091128B1 (hr)
CN (1) CN104540514B (hr)
AU (1) AU2013295227B2 (hr)
BR (1) BR112015001174B1 (hr)
CA (1) CA2879906A1 (hr)
DK (1) DK2877192T3 (hr)
ES (1) ES2590209T3 (hr)
HK (1) HK1209375A1 (hr)
HR (1) HRP20160774T1 (hr)
HU (1) HUE030002T2 (hr)
IL (1) IL236871B (hr)
IN (1) IN2015KN00222A (hr)
IT (1) ITMI20121317A1 (hr)
PL (1) PL2877192T3 (hr)
PT (1) PT2877192T (hr)
RU (1) RU2631612C2 (hr)
SG (1) SG11201500521XA (hr)
SI (1) SI2877192T1 (hr)
WO (1) WO2014016137A1 (hr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015030283A1 (ko) 2013-08-30 2015-03-05 주식회사 녹십자에이치에스 진세노사이드 성분이 증가된 가공인삼분말 또는 가공인삼추출물을 함유하는 암 관련 피로의 예방 및 치료용 조성물
CN108366974A (zh) * 2015-12-16 2018-08-03 维韦克·阿南德·帕拉库尔 天然化合物的三分子复合物
EP3335716A1 (en) * 2016-12-15 2018-06-20 Indena S.p.A. Process for the preparation of powder compositions
EP4340826A1 (en) 2021-05-18 2024-03-27 Prostasis, LLC Compositions comprising mixtures of compounds and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1215291B (it) * 1985-07-17 1990-01-31 Inverni Della Beffa Spa Complessi di flavanolignani con fosfolipidi, loro preparazione e relative composizioni farmaceutiche.
EP0464298B1 (en) 1990-07-05 1995-06-21 INDENA S.p.A. Echinacea extracts, a process for the preparation thereof and formulations containing them
CZ292832B6 (cs) * 2001-08-30 2003-12-17 Ivax Pharmaceuticals S.R.O. Způsob přípravy silymarinu se zvýšenou rozpustností
US20030206978A1 (en) * 2001-11-29 2003-11-06 Bob Sherwood Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
AU2004231997A1 (en) * 2003-04-16 2004-11-04 The University Of Mississippi Immunostimulatory agents in botanicals
US20050031710A1 (en) * 2003-08-08 2005-02-10 D'adamo Peter James Method of personal care and cosmetic product preparation and composition using human blood type
RU2277927C2 (ru) * 2004-09-15 2006-06-20 Наталья Ивановна Весельева Лечебно-профилактический комплекс "бальзам долголетие" общеукрепляющего и тонизирующего действия (варианты)
ITMI20090049A1 (it) * 2009-01-20 2010-07-21 Indena Spa Composizioni a base di estratti lipofili di zingiber officinale e di echinacea angustifolia per la prevenzione e il trattamento del riflusso gastro-esofageo e dell'emesi indotta da chemioterapici
CN101502320B (zh) * 2009-03-11 2012-09-05 王越 一种参姜红枣饮料冲剂的生产方法
IT1401141B1 (it) * 2010-07-26 2013-07-12 Indena Spa Formulazioni contenenti estratti di echinacea angustifolia e di zingiber officinale utili nella riduzione dell'infiammazione e del dolore periferico

Also Published As

Publication number Publication date
IL236871B (en) 2018-01-31
DK2877192T3 (en) 2016-09-05
AU2013295227B2 (en) 2017-04-27
WO2014016137A1 (en) 2014-01-30
AU2013295227A1 (en) 2015-02-19
EP2877192A1 (en) 2015-06-03
CA2879906A1 (en) 2014-01-30
HK1209375A1 (en) 2016-04-01
EP2877192B1 (en) 2016-06-08
BR112015001174A2 (pt) 2017-06-27
ES2590209T3 (es) 2016-11-18
JP6129314B2 (ja) 2017-05-17
PL2877192T3 (pl) 2016-12-30
US9566309B2 (en) 2017-02-14
BR112015001174B1 (pt) 2021-02-02
CN104540514A (zh) 2015-04-22
CN104540514B (zh) 2020-03-27
JP2015522631A (ja) 2015-08-06
SI2877192T1 (sl) 2016-09-30
RU2631612C2 (ru) 2017-09-25
KR102091128B1 (ko) 2020-03-20
ITMI20121317A1 (it) 2014-01-28
IN2015KN00222A (hr) 2015-06-12
KR20150037890A (ko) 2015-04-08
SG11201500521XA (en) 2015-02-27
RU2015102002A (ru) 2016-09-20
HUE030002T2 (en) 2017-04-28
PT2877192T (pt) 2016-09-13
US20150202246A1 (en) 2015-07-23

Similar Documents

Publication Publication Date Title
Alam et al. Traditional herbal medicines, bioactive metabolites, and plant products against COVID-19: update on clinical trials and mechanism of actions
Hartanti et al. The potential roles of jamu for COVID-19: a learn from the traditional Chinese medicine
HRP20160774T1 (hr) Pripravci za liječenje umora povezanog s karcinomom
Hakim et al. Gelam honey and ginger potentiate the anti cancer effect of 5-FU against HCT 116 colorectal cancer cells
Islam et al. A review on measures to rejuvenate immune system: Natural mode of protection against coronavirus infection
RU2017102952A (ru) Двухслойные таблетки, содержащие пробиотики, с двойным высвобождением
CN104306514A (zh) 一种中药喷剂及其制备方法
Fung et al. A randomized, double-blind, placebo-controlled study on the anti-haemostatic effects of Curcuma longa, Angelica sinensis and Panax ginseng
HRP20130977T1 (hr) Pripravci koji sadrže lipofilne ekstrakte zingiber officinale i echinacea angustifolia za prevenciju i lijeäśenje gastroezofagealne refluksne bolesti
SI2906233T1 (en) Pharmaceutical forms for the treatment and prevention of obesity
Al-Harrasi et al. Role of Essential Oils in the Management of COVID-19
Renjith et al. Scope of phytochemicals in the management of COVID-19
Jurcău et al. Eleutherococcus, Schisandra, Rhodiola and Ginseng, for stress and fatigue-a review
US20230029361A1 (en) Fagopyrum Nutraceutical Compositions
Fazel et al. Effect of cumin oil on post partum hemorrhage after cesarean
Qazi et al. A possible role of medicinal plants in finding a cure for covid-19
Attah et al. Therapeutic potentials of antiviral plants used in traditional african medicine with COVID-19 in focus: a Nigerian perspective. Front Pharmacol 12: 596855
De et al. Screening of Natural Antivirals Against the COVID-19 Pandemic-A Compilation of Updates
CN104338020A (zh) 一种治疗失眠的药物
CN103341111A (zh) 一种治疗遗精的中药组合物
Trivedi et al. Herbal medicine is the way of potential therapeutic option for the treatment of COVID-19: Recent updates
Hassan et al. Herbal Remedies Effective against COVID-19
Sargin et al. Immune-Boosting Plants Used in Turkish Folk Medicine and Their Potential Against COVID-19
CN103417699A (zh) 一种治疗脓疱疮的药物及其制备方法
CN102309735A (zh) 一种治疗癫痫的中药散剂